Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) EBIAT (2016 - 2023)

Historic EBIAT for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$22.0 million.

  • Mesoblast's EBIAT fell 56.79% to -$22.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$82.2 million, marking a year-over-year increase of 1068.55%. This contributed to the annual value of -$102.1 million for FY2025, which is 1612.85% down from last year.
  • According to the latest figures from Q2 2023, Mesoblast's EBIAT is -$22.0 million, which was down 56.79% from -$18.6 million recorded in Q1 2023.
  • Over the past 5 years, Mesoblast's EBIAT peaked at -$7.4 million during Q3 2019, and registered a low of -$29.4 million during Q1 2019.
  • Its 5-year average for EBIAT is -$22.5 million, with a median of -$22.4 million in 2021.
  • Its EBIAT has fluctuated over the past 5 years, first surged by 6455.07% in 2019, then plummeted by 25064.72% in 2020.
  • Quarter analysis of 5 years shows Mesoblast's EBIAT stood at -$29.1 million in 2019, then rose by 12.29% to -$25.5 million in 2020, then dropped by 2.2% to -$26.1 million in 2021, then rose by 5.66% to -$24.6 million in 2022, then grew by 10.84% to -$22.0 million in 2023.
  • Its EBIAT was -$22.0 million in Q2 2023, compared to -$18.6 million in Q1 2023 and -$24.6 million in Q4 2022.